BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1807447)

  • 1. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites.
    Brady JF; Ishizaki H; Fukuto JM; Lin MC; Fadel A; Gapac JM; Yang CS
    Chem Res Toxicol; 1991; 4(6):642-7. PubMed ID: 1807447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide.
    Brady JF; Wang MH; Hong JY; Xiao F; Li Y; Yoo JS; Ning SM; Lee MJ; Fukuto JM; Gapac JM
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):342-54. PubMed ID: 2017758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats.
    Jin L; Baillie TA
    Chem Res Toxicol; 1997 Mar; 10(3):318-27. PubMed ID: 9084912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
    Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
    J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cytochrome P450 2B1/2 genes by diallyl sulfone, disulfiram, and other organosulfur compounds in primary cultures of rat hepatocytes.
    Pan J; Hong JY; Li D; Schuetz EG; Guzelian PS; Huang W; Yang CS
    Biochem Pharmacol; 1993 Jun; 45(11):2323-9. PubMed ID: 8390837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cytochrome P450 2E1 and acetone catabolism in rats as studied with diallyl sulfide as an inhibitor.
    Chen L; Lee M; Hong JY; Huang W; Wang E; Yang CS
    Biochem Pharmacol; 1994 Dec; 48(12):2199-205. PubMed ID: 7811301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3.
    Morris CR; Chen SC; Zhou L; Schopfer LM; Ding X; Mirvish SS
    Nutr Cancer; 2004; 48(1):54-63. PubMed ID: 15203378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic.
    Yang CS; Chhabra SK; Hong JY; Smith TJ
    J Nutr; 2001 Mar; 131(3s):1041S-5S. PubMed ID: 11238812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from 1,1-dichloroethylene-induced Clara cell injury by diallyl sulfone, a derivative of garlic.
    Forkert PG; Lee RP; Dowsley TF; Hong JY; Ulreich JB
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1665-71. PubMed ID: 8667236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of N-alkylprotoporphyrin IX from metabolism of diallyl sulfone in lung and liver.
    Black GP; Collins KS; Blacquiere DP; Forkert PG
    Drug Metab Dispos; 2006 Jun; 34(6):895-900. PubMed ID: 16510538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds.
    Reicks MM; Crankshaw DL
    Nutr Cancer; 1996; 25(3):241-8. PubMed ID: 8771567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of hepatic catalase level by treatment with diallyl sulfide and garlic homogenates in rats and mice.
    Chen L; Hong JY; So E; Hussin AH; Cheng WF; Yang CS
    J Biochem Mol Toxicol; 1999; 13(3-4):127-34. PubMed ID: 10098897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone.
    Premdas PD; Bowers RJ; Forkert PG
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1112-20. PubMed ID: 10869417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of cytochrome P450 2B1/2 genes in rat liver by diallyl sulfide, a compound derived from garlic.
    Pan J; Hong JY; Ma BL; Ning SM; Paranawithana SR; Yang CS
    Arch Biochem Biophys; 1993 May; 302(2):337-42. PubMed ID: 8489239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats.
    Wu CC; Sheen LY; Chen HW; Kuo WW; Tsai SJ; Lii CK
    J Agric Food Chem; 2002 Jan; 50(2):378-83. PubMed ID: 11782211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide.
    Taubert D; Glöckner R; Müller D; Schömig E
    Toxicol Lett; 2006 Jun; 164(1):1-5. PubMed ID: 16337756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of organosulfur compounds as inhibitors of human CYP2A6.
    Fujita K; Kamataki T
    Drug Metab Dispos; 2001 Jul; 29(7):983-9. PubMed ID: 11408364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides.
    Siess MH; Le Bon AM; Canivenc-Lavier MC; Suschetet M
    Cancer Lett; 1997 Dec; 120(2):195-201. PubMed ID: 9461037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
    Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
    Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities.
    Brady JF; Li DC; Ishizaki H; Yang CS
    Cancer Res; 1988 Nov; 48(21):5937-40. PubMed ID: 3167846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.